Posts
January 28 2024
Processa Pharmaceuticals, Inc. announced the closing of its Public Offering in the amount of $7,000,000. EG&S acted as counsel to the Placement Agent.
January 26 2024
Client Alert: Employers to Provide a “Workers’ Bill of Rights” to All Employees Beginning July 1, 2024
New York City has enacted a law requiring all employers to provide their employees with a Worker’s Bill of Rights beginning on July 1, 2024. Employers will have to post and distribute it to all employees, regardless of immigration status.
Click here to read the alert.
January 26 2024
Akoustis Technologies, Inc. announced the closing of its Underwritten Public Offering in the amount of $11,500,000. EG&S acted as counsel to the Underwriter.
January 26 2024
Processa Pharmaceuticals, Inc. announced the closing of its Public Offering in the amount of $7,000,000. EG&S acted as counsel to the Placement Agent.
January 25 2024
Psyence Group Inc., a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, announced the completion of its subsidiary Psyence Biomedical Ltd’s merger with Newcourt Acquisition Corp, a special purpose acquisition company. The transaction is valued at approximately $50,000,000. EGS acted as counsel to Psyence Biomed II Corp. and its parent Psyence Group Inc.
January 25 2024
Douglas Ellenoff, a member of the Firm, was invited by SPAC Insider to join their panel of legal SPAC experts, to discuss the SEC’s new SPAC rules.
Click here to register.
January 24 2024
Akoustis Technologies, Inc. announced the closing of its Underwritten Public Offering in the amount of $11,500,000. EG&S acted as counsel to the Underwriter.
January 23 2024
Digital Brands Group, Inc. announced the commencement of its At The Market Offering in the amount of $1,806,937. EG&S acted as counsel to the Sales Agent.